Loading cancer entity…
Loading cancer entity…
Clinical trials
536 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02822495 | Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies | no longer available | — | — | Atara BiotherapeuticsINDUSTRY | 0 | Jun 15, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Jun 15, 2023source: clinicaltrials